HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hani N Sabbah Selected Research

Myosin Heavy Chains (Myosin Heavy Chain)

12/2006Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension.
11/2003Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hani N Sabbah Research Topics

Disease

109Heart Failure
05/2023 - 03/2002
15Hypertrophy
01/2017 - 05/2002
13Left Ventricular Dysfunction
11/2012 - 05/2002
9Fibrosis (Cirrhosis)
06/2017 - 09/2002
7Ventricular Remodeling
01/2017 - 12/2006
6Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2007
6Cardiomyopathies (Cardiomyopathy)
01/2022 - 09/2002
6Hypertension (High Blood Pressure)
12/2013 - 10/2002
5Myocardial Infarction
03/2023 - 11/2012
5Inflammation (Inflammations)
01/2023 - 02/2009
4Infarction (Infarctions)
02/2016 - 12/2005
4Necrosis
07/2009 - 04/2004
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
08/2007 - 03/2002
3Barth Syndrome
01/2023 - 01/2021
3Hyperemia
03/2017 - 02/2014
3Hypoxia (Hypoxemia)
12/2008 - 09/2002
2Systolic Heart Failure
02/2021 - 11/2012
2Cicatrix (Scar)
12/2020 - 12/2014
2Ischemia
12/2020 - 12/2013
2Cardio-Renal Syndrome
11/2020 - 03/2013
2Disease Progression
11/2017 - 01/2017
2Ventricular Dysfunction
01/2017 - 12/2005
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2013 - 12/2006
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2009 - 12/2005
2Mitral Valve Insufficiency (Mitral Regurgitation)
06/2005 - 12/2004
1Right Ventricular Dysfunction
01/2023
1Stroke (Strokes)
01/2023

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
12/2013 - 03/2002
12Messenger RNA (mRNA)IBA
12/2014 - 11/2003
9arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
01/2023 - 12/2014
6CalciumIBA
01/2017 - 11/2003
5CytokinesIBA
01/2023 - 02/2007
5Adenosine Triphosphatases (ATPase)IBA
01/2021 - 03/2002
5SodiumIBA
01/2013 - 05/2006
5Fatty Acids (Saturated Fatty Acids)IBA
02/2012 - 12/2002
5IstaroximeIBA
12/2009 - 01/2007
4Therapeutic UsesIBA
01/2023 - 02/2009
4salicylhydroxamic acid (SHAM)IBA
12/2020 - 03/2003
4EnzymesIBA
11/2020 - 12/2006
4Peptides (Polypeptides)IBA
01/2018 - 12/2014
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016 - 01/2013
4Natriuretic PeptidesIBA
12/2015 - 10/2013
4Glucose (Dextrose)FDA LinkGeneric
05/2013 - 10/2004
4RanolazineFDA Link
11/2008 - 08/2002
3Brain Natriuretic Peptide (Natrecor)FDA Link
05/2023 - 05/2013
3Biomarkers (Surrogate Marker)IBA
11/2020 - 07/2009
3Adenosine (Adenocard)FDA LinkGeneric
01/2017 - 05/2013
3HydrogelsIBA
03/2016 - 06/2013
3AlginatesIBA
03/2016 - 06/2013
3AldosteroneIBA
12/2013 - 12/2002
3Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2013 - 03/2003
3Metoprolol (Toprol-XL)FDA LinkGeneric
01/2009 - 09/2002
3Matrix Metalloproteinases (MMPs)IBA
01/2008 - 06/2006
2Cardiolipins (Cardiolipin)IBA
01/2023 - 01/2016
2Neprilysin (Neutral Endopeptidase)IBA
11/2020 - 05/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2020 - 08/2007
2nitroxylIBA
10/2018 - 11/2013
2Guanosine Monophosphate (5' Guanylic Acid)IBA
12/2015 - 03/2013
2IvabradineIBA
12/2014 - 01/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
12/2014 - 02/2014
2LipidsIBA
12/2013 - 12/2006
2Docosahexaenoic AcidsIBA
12/2013 - 01/2013
2DiureticsIBA
03/2013 - 05/2002
2Oxidoreductases (Dehydrogenase)IBA
01/2013 - 08/2007
2NADP (NADPH)IBA
01/2013 - 08/2007
2Arginine Vasopressin (Argipressin)IBA
01/2013 - 01/2011
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2013 - 02/2009
2Nitric Oxide Synthase (NO Synthase)IBA
01/2012 - 01/2011
2Carrier Proteins (Binding Protein)IBA
01/2012 - 06/2009
2Protein Isoforms (Isoforms)IBA
01/2012 - 11/2003
2Rosuvastatin Calcium (Crestor)FDA Link
01/2012 - 08/2007
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2012 - 03/2002
2Phosphotransferases (Kinase)IBA
01/2012 - 01/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 10/2005
2N-acetyltalosaminuronic acid (NAT)IBA
10/2011 - 05/2006
2Adrenergic Receptors (Adrenergic Receptor)IBA
08/2011 - 01/2011
2AdiponectinIBA
06/2010 - 02/2009
2Milrinone (Primacor)FDA LinkGeneric
07/2009 - 01/2007
2Caspase 3 (Caspase-3)IBA
12/2008 - 09/2002
2Cytoskeletal ProteinsIBA
01/2008 - 12/2007
2Eplerenone (Inspra)FDA LinkGeneric
12/2007 - 12/2002
2VimentinIBA
12/2007 - 12/2005
2Fibronectins (Fibronectin)IBA
12/2007 - 12/2005
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2006 - 11/2003
2Atrial Natriuretic Factor (ANF)IBA
12/2006 - 05/2002
2Oxygen (Dioxygen)IBA
06/2005 - 12/2004
2Adrenergic Agents (Adrenergic Drugs)IBA
04/2004 - 06/2002
2Calcium-Calmodulin-Dependent Protein KinasesIBA
03/2003 - 03/2002
1pro-brain natriuretic peptide (1-76)IBA
05/2023
1goralatideIBA
03/2023
1InterleukinsIBA
01/2023
1Monocyte Chemoattractant ProteinsIBA
01/2023

Therapy/Procedure

49Therapeutics
01/2023 - 12/2002
6Intravenous Infusions
02/2021 - 11/2008
5Patient Readmission
01/2022 - 07/2008
4Vagus Nerve Stimulation
12/2013 - 02/2009
3Injections
03/2016 - 04/2011
3Surgical Instruments (Clip)
01/2005 - 10/2002
2Heart Transplantation (Grafting, Heart)
01/2023 - 09/2002
2Fat-Restricted Diet (Diet, Fat Restricted)
01/2012 - 12/2006